ELEDON PHARMACEUTICALS
3.9800
25-十一月-24 14:19:10
15 分钟延时
股票
-0.0300
-0.75%
今日范围
3.9500 - 4.1250
ISIN
N/A
来源
NASDAQ
-
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
12 11月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
06 11月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
29 10月 2024 06:46:00 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
11 9月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
04 9月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results
14 8月 2024 16:21:26 条件 Nasdaq GlobeNewswire
-
29 7月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
02 7月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
03 6月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
09 5月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
09 5月 2024 06:00:01 条件 Nasdaq GlobeNewswire
-
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
07 5月 2024 06:05:00 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
07 5月 2024 06:00:01 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
28 3月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
25 3月 2024 15:56:42 条件 Nasdaq GlobeNewswire
-
21 3月 2024 09:31:12 条件 Nasdaq GlobeNewswire
-
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 2月 2024 18:01:00 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
04 1月 2024 15:40:44 条件 Nasdaq GlobeNewswire
-
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 12月 2023 17:00:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >